MedPath

Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG

Not Applicable
Completed
Conditions
Bowel Preparation
Interventions
Drug: 2L PEG-Asc
Drug: 1L PEG-Asc
Registration Number
NCT03849196
Lead Sponsor
Samsung Medical Center
Brief Summary

Proper bowel cleansing before colonoscopy is an important factor to increase the detection rate of lesions. Low volume polyethylene glycol (PEG) plus ascorbic (PEG-Asc) has reduced the dosage of previous bowel preparation agent, but it still presents discomfort to patients. The aim of this study was to confirm the efficacy and convenience of volume reduction of PEG-Asc by adding bisacodyl suppository at the same day by compared with conventional 2L PEG-Asc.

Detailed Description

Eligibility criteria: outpatients between the ages of 20 and 70 years, who were scheduled for colonoscopy between August 2017 and January 2018

Exclusion criteria: patients with a history of gastrointestinal tract surgery, inflammatory bowel disease, severe active colitis, underlying chronic kidney disease, or pregnancy.

Outcome measures: the Boston Bowel Preparation Scale (BBPS)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
168
Inclusion Criteria
  • outpatients who were scheduled for colonoscopy between August 2017 and January 2018
Exclusion Criteria
  • History of gastrointestinal tract surgery
  • History of inflammatory bowel disease
  • History of severe active colitis
  • History of chronic kidney disease
  • pregnant woman.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2L PEG-Asc2L PEG-Asc2L PEG-Asc for bowel preparation
1L PEG-Asc & 'Bisacodyl 10Mg SuppositoryBisacodyl 10Mg Suppository1L PEG-Asc with 'Bisacodyl 10Mg Suppository for bowel preparation
1L PEG-Asc & 'Bisacodyl 10Mg Suppository1L PEG-Asc1L PEG-Asc with 'Bisacodyl 10Mg Suppository for bowel preparation
Primary Outcome Measures
NameTimeMethod
Boston Bowel Preparation Scale (BBPS).1 hour

4-point scoring system (0-3) applied to each of the 3 colon segments (right colon including cecum and ascending colon, transverse colon including transverse colon, hepatic and splenic flexure, left colon including descending colon, sigmoid colon, and rectum)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath